logologo

close

COPYRIGHT 2020 POSVAX CO. LTD. ALL RIGHTS RESERVED.

R&D

RESEARCH PAPERS

Research papers 목록
2020 Current status and future directions of fish vaccines employing virus-like particles
2019 IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation
2018 Comparison of the size distributions and immunogenicity of human papillomavirus type 16 L1 virus-like particles produced in insect and yeast cells
2018 Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles
2017 Current status and future direction of human papillomavirus vaccines
2017 Oral vaccination through voluntary consumption of the convict grouper Epinephelus septemfasciatus with yeast producing the capsid protein of red-spotted grouper nervous necrosis virus
2017 Yeast as an expression system for producing virus-like particles: what factors do we need to consider?
2016 Characterization of human papillomavirus type 16 pseudovirus containing histones
2016 Heparin chromatography-mediated assembly of capsid proteins of red-spotted grouper nervous necrosis virus and role of calcium ion in the chromatography
2015 Protective immunity against nervous necrosis virus in convict grouper Epinephelus septemfasciatus following vaccination with virus-like particles produced in yeast Saccharomyces cerevisiae
2014 The concentration of carbon source in the medium affects the quality of virus-like particles of human papillomavirus type 16 produced in Saccharomyces cerevisiae
2014 Oral immunization with whole yeast producing viral capsid antigen provokes a stronger humoral immune response than purified viral capsid antigen
2013 A comparative study of the adjuvanticity of Hansenula polymorpha, Saccharomyces cerevisiae and Yarrowia lipolytica in oral and nasal immunization with virus capsid antigens
2013 Chromatographically-purified capsid proteins of red-spotted grouper nervous necrosis virus expressed in Saccharomyces cerevisiae form virus-like particles
2013 Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae
2012 The production and immunogenicity of human papillomavirus type 58 virus-like particles produced in Saccharomyces cerevisiae
2012 Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles
2012 The choice of resin-bound ligand affects the structure and immunogenicity of column-purified human papillomavirus type 16 virus-like particles